Top 10 Fast-growings companies in Carbonic anhydrase inhibitor by Most Patent Filing In 5 Years in the United States in 2022 – Discovery

Free Trial

The Carbonic anhydrase inhibitor top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 5 Years Carbonic anhydrase inhibitor Fast-growings in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	Ocuphire Pharma, Inc.	Michigan, United States	OPHTHALMIC DISORDERS,Glaucoma,Eye drop, ...[+2]	Patent: 5
2	STARTUP Somerset Therapeutics LLC	New Jersey, United States	Drug,Ophthalmic drugs,Health care, ...[+1]	Patent: 4
3	Ocugen, Inc.	Pennsylvania, United States	Medicine,Health care,Biopharmaceutical, ...[+2]	Patent: 3
4	Purdue Research Foundation	Indiana, United States	Financial asset,Technology transfer,Incubation, ...[+2]	Patent: 3
5	Graybug Vision, Inc.	United States	Medicine,Health care,Glaucoma, ...[+2]	Patent: 2
6	The Brigham & Women's Hospital, Inc.	Massachusetts, United States	Health care,Mitral valve surgery,Health equity, ...[+2]	Patent: 2
7	VIVUS, Inc.	California, United States	Medicine,Health care,Obesity, ...[+2]	Patent: 1
8	University Hospitals Cleveland Medical Center	Ohio, United States	Primary care physician,Health care,Hospitality industry, ...[+2]	Patent: 1
9	The University of Texas at Austin	Texas, United States	Undergraduate education,Career development,Association (object-oriented programming), ...[+2]	Patent: 1
10	The University of Texas at Arlington	Texas, United States	Library science,Community engagement,Critical thinker, ...[+2]	Patent: 1